NCT05184088 - Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Cardiac AmyloidosisAL AmyloidosisATTR Amyloidosis

Interventions

DRUG

[18F]florbetaben

All enrolled patients will undergo \[18F\]florbetaben PET imaging.

Trial Locations (14)

13353

RECRUITING

Charite Berlin, Berlin

15213

RECRUITING

University of Pittsburgh, Pittsburgh

19104

RECRUITING

University of Pennsylvania, Philadelphia

22767

RECRUITING

HOPA Hamburg, Hamburg

28222

RECRUITING

Hospital University Puerta de Hierro, Madrid

31008

RECRUITING

Clínica Universidad de Navarra, Pamplona

37007

RECRUITING

University of Salamanca, Salamanca

45147

RECRUITING

University of Essen, Essen

64111

RECRUITING

St Luke's Hospital, Kansas City

69120

RECRUITING

University of Heidelberg, Heidelberg

86156

RECRUITING

University of Augsburg, Augsburg

97080

RECRUITING

University of Würzburg, Würzburg

08907

RECRUITING

Hospital University Bellvitge, Barcelona

NW3 2PF

RECRUITING

Royal Free Hospital, London